SLC5A2 and heart failure: A notable breakthrough in combating heart failure isthe utilization of sodium-glucose cotransporter-2 (SGLT2) inhibitors, which haveproven effective in reducing left ventricular mass in participants with LVH andtype-2 diabetes [22].